Research released today, funded by the MND Association, has found higher than expected genetic changes in a group of 100 MND patients.
Researchers from the Sheffield Institute for Translational Neuroscience (SITraN), part of the AMBRoSIA biobank, suggest that offering routine genetic testing to MND patients could impact on disease sub-classification and clinical care.
You can find out more in our latest news story here https://www.mndassociation.org/sitranstudy/
Researchers from the Sheffield Institute for Translational Neuroscience (SITraN), part of the AMBRoSIA biobank, suggest that offering routine genetic testing to MND patients could impact on disease sub-classification and clinical care.
You can find out more in our latest news story here https://www.mndassociation.org/sitranstudy/
Comment